Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
about
Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant.Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin.Cytoprotective and pro-angiogenic functions of thrombomodulin are preserved in the C loop of the fifth epidermal growth factor-like domain
P2860
Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@ast
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@en
type
label
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@ast
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@en
prefLabel
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@ast
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@en
P2093
P2860
P356
P1433
P1476
Treatment of thrombotic microa ...... human soluble thrombomodulin.
@en
P2093
Hideaki Fujiwara
Hisakazu Nishimori
Katsuma Tani
Ken-Ichi Matsuoka
Makoto Nakamura
Nobuharu Fujii
Tatsunori Ishikawa
Yasuhisa Sando
Yoshinobu Maeda
P2860
P304
P356
10.1111/TRF.13437
P577
2015-12-29T00:00:00Z